Lionel Piroth
Biographic Data
| ID | 7450533 |
|---|---|
| NAME | Lionel Piroth |
| GIVEN NAMES | Lionel |
| FAMILY NAME | Piroth |
| SIGNATURE | PIROTH L |
| AFFILIATIONS | Inserm |
| ORCID | 0000-0003-4478-1032 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Sexual health indicators among young adults living with perinatally-acquired HIV in france, a gender-stratified comparison with their peers in the general population
The COVERTE study received approval from the CPP III (n°2738). For the BS surveys, the CNIL approved each survey (n°915589)
Tobacco use in people living with HIV
HCV-Related Mortality Among HIV/HCV Co-infected Patients
Preexposure prophylaxis (PrEP) of HIV infection in France
Although preliminary studies showed that preexposure prophylaxis (PrEP) lowers the HIV transmission in individuals with HIV, confirmative trials are ongoing and PrEP is not routinely recommended. The aim of this study was to assess whether individuals with HIV share antiretroviral (ARV) drugs for PrEP and to describe awareness and discussion on PrEP in this population. A cross-sectional survey was conducted in France in 23 representative departme…
No prominent works on this page.
Preexposure prophylaxis (PrEP) of HIV infection in France
Although preliminary studies showed that preexposure prophylaxis (PrEP) lowers the HIV transmission in individuals with HIV, confirmative trials are ongoing and PrEP is not routinely recommended. The aim of this study was to assess whether individuals with HIV share antiretroviral (ARV) drugs for PrEP and to describe awareness and discussion on PrEP in this population. A cross-sectional survey was conducted in France in 23 representative departme…
HCV-Related Mortality Among HIV/HCV Co-infected Patients
Tobacco use in people living with HIV
Sexual health indicators among young adults living with perinatally-acquired HIV in france, a gender-stratified comparison with their peers in the general population
The COVERTE study received approval from the CPP III (n°2738). For the BS surveys, the CNIL approved each survey (n°915589)
HIV/AIDS Research and Interventions (3 works) · Medicine (3 works) · Environmental health (2 works) · Family medicine (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Human immunodeficiency virus (HIV (2 works) · Internal Medicine (2 works) · Population (2 works) · Young adult (2 works) · Advertising (1 work)